Plain-English translation of NCT06769828 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new type of imaging scan called PET to help detect if colorectal cancer has come back in patients whose blood tests show rising cancer markers. The scan works by targeting special proteins that are often found in cancer tissue, which may make it better at finding recurrent cancer than older imaging methods. You would receive this new scan and also have a standard scan so doctors can compare how well each one works.
When colorectal cancer comes back after surgery, finding it as early as possible is critical so doctors can treat it quickly. Right now, when a patient's cancer marker blood test rises, doctors use standard imaging to look for the cancer, but this new treatment may be better at spotting it and could help catch recurrence sooner.
You likely qualify if…
You likely don't qualify if…
You would have two imaging scans performed within 2 weeks of each other. For each scan, you'll receive an injection of the imaging medication through an IV, then wait 30–90 minutes while it circulates through your body, and finally lie still in a scanner for the imaging to be completed. The scans are painless, and your results will be compared to help doctors understand how well this new imaging method works at detecting cancer recurrence.
AI-generated summary from trial data · Jul 15, 2026 · Not medical advice
Taiwan